Description

Methyl 7-Fluoro-3-Oxo-3,4-Dihydroquinoxaline-2-Carboxylate is a high-purity fluorinated heterocyclic building block of significant interest in advanced organic synthesis. Its core value lies in its role as a versatile intermediate for constructing complex molecular architectures, particularly in the development of novel active pharmaceutical ingredients (APIs). This compound is essential for research and production teams in the pharmaceutical, agrochemical, and specialty chemical industries seeking to incorporate the quinoxaline pharmacophore into new compounds.

Application

• Pharmaceutical Intermediate: Key precursor in the synthesis of potential drug candidates, especially those targeting central nervous system (CNS) disorders, oncology, and anti-infective agents.
• Agrochemical Research: Used in developing new herbicides, fungicides, and insecticides, leveraging the biological activity of the fluorinated quinoxaline scaffold.
• Material Science: Serves as a building block for creating advanced organic electronic materials, such as organic light-emitting diodes (OLEDs) and semiconductors.
• Chemical Biology Probe Development: Utilized in designing molecular probes and inhibitors for studying enzyme function and biological pathways.
• Custom Synthesis & Contract Manufacturing: A critical starting material for custom synthesis projects and contract research organizations (CROs/CMOs) serving the life sciences sector.

Basic Information

Product Name	Methyl 7-Fluoro-3-Oxo-3,4-Dihydroquinoxaline-2-Carboxylate
CAS No.	221167-39-1
Molecular Formula	C10H7FN2O3
Molecular Weight	222.17 g/mol
Synonyms	Methyl 7-fluoro-3-oxo-3,4-dihydro-2-quinoxalinecarboxylate; 7-Fluoro-3-oxo-3,4-dihydroquinoxaline-2-carboxylic acid methyl ester; 2-Quinoxalinecarboxylic acid, 3,4-dihydro-7-fluoro-3-oxo-, methyl ester; 7-Fluoro-2-methoxycarbonyl-3,4-dihydroquinoxalin-3-one; Methyl 7-fluoro-3-oxo-3,4-dihydroquinoxaline-2-carboxylate; 221167-39-1
EINECS	Contact for details

Quality Control

Our production of Methyl 7-Fluoro-3-Oxo-3,4-Dihydroquinoxaline-2-Carboxylate adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity. Each lot undergoes comprehensive analytical testing, including HPLC, NMR, and MS, to confirm identity and purity. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting all critical quality attributes. We support compliance with cGMP and ICH guidelines for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.